跳至主要内容
临床试验/CTRI/2025/04/085332
CTRI/2025/04/085332尚未招募不适用

Randomized Controlled Trial on Efficacy of Karpas Moola Churna in Shwetapradar With Special Reference to Bacterial Vaginosis

Snehal Pralhad Patil1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2025年2月6日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
To observe the effect of karpas moola churna to change in value of vaginal PH in bacterial vaginosis

研究概览

简要总结

This is an open labelled randomized controlled clinical study.The aim of this study is to evaluate the efficacy of karpas moola churna in the management of shwetapradar with special reference to bacterial vaginosis.Total 44 participants will be enrolled in 2 groups(22 in each group).Group A(Trial group)will be treated with Karpas moola churna and Group B(Controlled group)will be treated with Tablet Metronidazole.Age group for an inclusion criteria will be 21-45 years female with the symptoms of bacterial vaginosis.The final conclusion will be drawn on the basis of statistical methods.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
21.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Patient with Symptoms of Bacterial Vaginosis Whitish or Yellowish-white or Grayish-white,milky,malodorous,thin,adherent vaginal discharge Vaginal pH-more than 4.5 Wet Mount Test-Positive for Bacterial Vaginosis.

排除标准

  • Pregnant women Genital Prolapsed Pelvic Inflammatory disease Other Vaginal Infections like vaginal Candidiasis,Chlamydia Bacterial Infection,Trichomonas Vaginalis.

结局指标

主要结局

To observe the effect of karpas moola churna to change in value of vaginal PH in bacterial vaginosis

时间窗: Twice a day for 7 days

次要结局

  • To observe the effect of karpas moola churna to reduce the symptom of vaginal discharge in bacterial vaginosis(Twice a day for 7 days)

研究者

发起方
Snehal Pralhad Patil
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验